First biotech company to announce commercial use of bridge RNA-guided DNA recombination by end of 2024? | Categorical | | | 6 months ago | |
Human clinical trial of bridge RNA-guided DNA recombination by end of 2024? | Binary | | | 6 months ago | |
Arc Institute partnership with major pharma for bridge RNA-guided DNA recombination by end of 2024? | Binary | | | 6 months ago | |
First crop species genetically modified using bridge RNA-guided DNA recombination by end of 2024? | Categorical | | | 6 months ago | |
FDA approval for clinical trials using new RNA-guided recombinase system by June 30, 2025? | Binary | | | 6 months ago | |
Partnership between Arc Institute and a major biotechnology company announced by December 31, 2024? | Binary | | | 6 months ago | |
First commercial application of the new RNA-guided recombinase system by December 31, 2024? | Categorical | | | 6 months ago | |
First major regulatory approval for a product using the new RNA-guided recombinase system by December 31, 2025? | Categorical | | | 6 months ago | |
First animal species modified using bridge RNA-guided DNA recombination by end of 2024? | Categorical | | | 6 months ago | |
Study on bridge RNA-guided DNA recombination in animal models by end of 2024? | Binary | | | 6 months ago | |
At least 5 research papers using the new RNA-guided recombinase system published by December 31, 2024? | Binary | | | 6 months ago | |
Most cited application area for the new RNA-guided recombinase system in 2024? | Categorical | | | 6 months ago | |
